Terns Pharmaceuticals, Inc.
TERN
Revenue
0.00
▼-1.00M▼-100.00%
12 Months ChangeAssets
230.88M
▼-15.89M▼-6.44%
3 Months ChangeLiabilities
12.20M
▲2.15M▲21.43%
3 Months ChangeFree Cash Flow
-22.83M
▼-8.45M▼-58.72%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-12
Form 8-K
ID: 0001193125-24-217444
2024-09-09
Form 8-K
ID: 0000950170-24-104550
2024-08-05
Form 10-Q
ID: 0000950170-24-090925
2024-08-05
Form 8-K
ID: 0000950170-24-090761
2024-07-29
Form 8-K
ID: 0000950170-24-087284
2024-07-03
Form 8-K
ID: 0000950170-24-081531
2024-06-12
Form 8-K
ID: 0000950170-24-072462
2024-05-13
Form 10-Q
ID: 0000950170-24-058672
2024-05-13
Form 8-K
ID: 0000950170-24-058209
2024-04-29
Form 8-K
ID: 0000950170-24-049870